Evidence map›Paper›PMID 29590119›Full record

ArticlePloS one2018

NF90/ILF3 is a transcription factor that promotes proliferation over differentiation by hierarchical regulation in K562 erythroleukemia cells.

Ting-Hsuan Wu, Lingfang Shi, Jessika Adrian, Minyi Shi, Ramesh V Nair, Michael P Snyder, Peter N Kao

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The role of circular RNAs in autoimmune diseases: Potential diagnostic biomarkers and therapeutic targets.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. The Polyvalent Role of NF90 in RNA Biology.International journal of molecular sciences · 2022
    Review
  9. DNA and RNA Binding Proteins: From Motifs to Roles in Cancer.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ting-Hsuan WuPulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
Lingfang ShiPulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America.
Jessika AdrianDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Minyi ShiDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Ramesh V NairStanford Center for Genomics and Personalized Medicine, Stanford University School of Medicine, Palo Alto, California, United States of America.
Michael P SnyderDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Peter N KaoPulmonary and Critical Care Medicine, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-2968-5456
Stanford University · US

Funding

Production Center for Mapping Regulatory Regions of the Human GenomeU54HG006996 · NHGRI · STANFORD UNIVERSITY · PI SNYDER, MICHAEL P. · 2012 to 2016
$14.6M
T CELLS IN LUNG INFLAMMATIONR01AI039624 · NIAID · STANFORD UNIVERSITY · PI KAO, PETER N · 1996 to 2011
$3.4M
NHGRI NIH HHS U54 HG006996NIAID NIH HHS R01 AI039624NIH HHS U54 HG006996
6 · The paper itself

Abstract

NF90 and splice variant NF110 are DNA- and RNA-binding proteins encoded by the Interleukin enhancer-binding factor 3 (ILF3) gene that have been established to regulate RNA splicing, stabilization and export. The roles of NF90 and NF110 in regulating transcription as chromatin-interacting proteins have not been comprehensively characterized. Here, chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) identified 9,081 genomic sites specifically occupied by NF90/NF110 in K562 cells. One third of NF90/NF110 peaks occurred at promoters of annotated genes. NF90/NF110 occupancy colocalized with chromatin marks associated with active promoters and strong enhancers. Comparison with 150 ENCODE ChIP-seq experiments revealed that NF90/NF110 clustered with transcription factors exhibiting preference for promoters over enhancers (POLR2A, MYC, YY1). Differential gene expression analysis following shRNA knockdown of NF90/NF110 in K562 cells revealed that NF90/NF110 activates transcription factors that drive growth and proliferation (EGR1, MYC), while attenuating differentiation along the erythroid lineage (KLF1). NF90/NF110 associates with chromatin to hierarchically regulate transcription factors that promote proliferation and suppress differentiation.

Indexed as

Gene Expression Regulation, LeukemicBase SequenceCell DifferentiationCell ProliferationChromatinEnhancer Elements, GeneticGene Expression ProfilingHumansK562 CellsLeukemia, Erythroblastic, AcuteNuclear Factor 90 ProteinsPromoter Regions, GeneticProtein BindingRNA InterferenceChromatinNuclear Factor 90 Proteins

Identifiers

PMID29590119
PMCPMC5873942
OpenAlexW2951656697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.